CXCL10 and COVID-19: Critical COVID-19 patients also present IP-10 driven extrafollicular humoral responses, which are strongly correlated with large antibody-secreting cells expansion and early production of high concentrations of SARS-CoV-2-specific neutralizing antibodies (31).